Elijah is a business, intellectual property, entertainment, and litigation attorney. A collaborative team member and keen negotiator, he helps businesses navigate complex problems with simple and straightforward solutions. Whether working hands-on with clients to develop and protect their brands, or spearheading a novel legal matter, Elijah is dedicated to crafting meaningful and lasting legal solutions for his clients.
A new age for psychedelics We are on the verge of a psychedelic renaissance, with the Food and Drug Administration (FDA) accepting a new drug application for midmafetamine (MDMA) in February of this year. MDMA the active ingredient in the common party drug “ecstasy” or “molly”. If approved, the drug would be used to treat
